Table 3 Stepwise regression models of PANSS total and subscore in CR-TRS patients without MetSa.

From: Association of cytokines levels, psychopathology and cognition among CR-TRS patients with metabolic syndrome

Outcome

Predictors

Patients without MetS (n = 38)

β

t

p

PANSS

Total score

IL-2 (pg/mL)

0.454

3.059

0.004

P subscore

IL-2 (pg/mL)

0.347

2.220

0.033

G subscore

IL-2 (pg/mL)

0.437

2.915

0.006

P subscore

IL-6 (pg/mL)

–0.413

–2.723

0.010

RBANS

Delayed memory

IL-6 (pg/mL)

0.404

2.647

0.012

  1. PANSS Positive and Negative Syndrome Scale, CR-TRS Clozapine-resistant treatment-refractory schizophrenia, MetS Metabolic Syndrome, P positive symptom, N negative symptom, G general psychopathology syndrome, RBANS Repeatable Battery for the Assessment of Neuropsychological Status, IL-2 interleukin-2, IL-6 interleukin-6.
  2. aAfter controlling for age, gender, body mass index (BMI).
Back to article page